These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

318 related items for PubMed ID: 1423304

  • 1. Frequent p53 gene mutations in blast crisis of chronic myelogenous leukemia, especially in myeloid crisis harboring loss of a chromosome 17p.
    Nakai H, Misawa S, Toguchida J, Yandell DW, Ishizaki K.
    Cancer Res; 1992 Dec 01; 52(23):6588-93. PubMed ID: 1423304
    [Abstract] [Full Text] [Related]

  • 2. Monoallelic deletions of the P53 gene in Chinese patients with chronic myelogenous leukemia in blastic crisis.
    Chen SJ, Wang Q, Tong JH, Xie WJ, Cao Q, Cai JR, Li XS, Wang ZY, Chen Z, Larsen CJ.
    Nouv Rev Fr Hematol (1978); 1991 Dec 01; 33(6):481-4. PubMed ID: 1818302
    [Abstract] [Full Text] [Related]

  • 3. [Molecular analysis of transformation into blast crisis in chronic myelogenous leukemia].
    Okabe M.
    Hokkaido Igaku Zasshi; 1993 Mar 01; 68(2):237-50. PubMed ID: 8509066
    [Abstract] [Full Text] [Related]

  • 4. p53 gene mutations and loss of a chromosome 17p in Philadelphia chromosome (Ph1)-positive acute leukemia.
    Nakai H, Misawa S, Tanaka S, Nishigaki H, Taniwaki M, Yokota S, Horiike S, Takashima T, Seriu T, Nakagawa H.
    Leukemia; 1993 Oct 01; 7(10):1547-51. PubMed ID: 8412316
    [Abstract] [Full Text] [Related]

  • 5. Absence of N-ras mutations in myeloid and lymphoid blast crisis of chronic myeloid leukemia.
    Watzinger F, Gaiger A, Karlic H, Becher R, Pillwein K, Lion T.
    Cancer Res; 1994 Jul 15; 54(14):3934-8. PubMed ID: 8033117
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. p53 mutations in human malignant gliomas: comparison of loss of heterozygosity with mutation frequency.
    Frankel RH, Bayona W, Koslow M, Newcomb EW.
    Cancer Res; 1992 Mar 15; 52(6):1427-33. PubMed ID: 1347252
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. P53 tumor suppressor gene in chronic myelogenous leukemia: a sequential study.
    Rovira A, Urbano-Ispizua A, Cervantes F, Rozman M, Vives-Corrons JL, Montserrat E, Rozman C.
    Ann Hematol; 1995 Mar 15; 70(3):129-33. PubMed ID: 7718641
    [Abstract] [Full Text] [Related]

  • 16. p53 gene mutations in medulloblastoma. Immunohistochemistry, gel shift analysis, and sequencing.
    Badiali M, Iolascon A, Loda M, Scheithauer BW, Basso G, Trentini GP, Giangaspero F.
    Diagn Mol Pathol; 1993 Mar 15; 2(1):23-8. PubMed ID: 8287222
    [Abstract] [Full Text] [Related]

  • 17. Analysis of the p53 gene in patients with isochromosome 17q and Ph1-positive or -negative myeloid leukemia.
    Schütte J, Opalka B, Becher R, Bardenheuer W, Szymanski S, Lux A, Seeber S.
    Leuk Res; 1993 Jun 15; 17(6):533-9. PubMed ID: 8505851
    [Abstract] [Full Text] [Related]

  • 18. Prognostic significance of loss of a chromosome 17p and p53 gene mutations in blast crisis of chronic myelogenous leukaemia.
    Nakai H, Misawa S, Taniwaki M, Horiike S, Takashima T, Seriu T, Nakagawa H, Fujii H, Shimazaki C, Maruo N.
    Br J Haematol; 1994 Jun 15; 87(2):425-7. PubMed ID: 7947294
    [Abstract] [Full Text] [Related]

  • 19. A study on the incidence of ABL gene deletion on derivative chromosome 9 in chronic myelogenous leukemia by interphase fluorescence in situ hybridization and its association with disease progression.
    Lee DS, Lee YS, Yun YS, Kim YR, Jeong SS, Lee YK, She CJ, Yoon SS, Shin HR, Kim Y, Cho HI.
    Genes Chromosomes Cancer; 2003 Jul 15; 37(3):291-9. PubMed ID: 12759927
    [Abstract] [Full Text] [Related]

  • 20. Contribution of ABL kinase domain mutations to imatinib resistance in different subsets of Philadelphia-positive patients: by the GIMEMA Working Party on Chronic Myeloid Leukemia.
    Soverini S, Colarossi S, Gnani A, Rosti G, Castagnetti F, Poerio A, Iacobucci I, Amabile M, Abruzzese E, Orlandi E, Radaelli F, Ciccone F, Tiribelli M, di Lorenzo R, Caracciolo C, Izzo B, Pane F, Saglio G, Baccarani M, Martinelli G, GIMEMA Working Party on Chronic Myeloid Leukemia.
    Clin Cancer Res; 2006 Dec 15; 12(24):7374-9. PubMed ID: 17189410
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.